Prophylaxis of Chemotherapy-induced Neutropenia and Febrile Neutropenia with Lipegfilgrastim in Patients with Non-Hodgkin Lymphoma (NADIR study). 26. Juli 2018 Wolff, T., Schulz, H., Losem, C., Reichert, D., Hurtz, H.-J., Sandner, R., Harde, J., Grebhardt, S., Potthoff, K., Mueller, U., Fietz, T., 2019. Eur J Hematol. doi:10.1111/ejh.13189 Abstract Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry. Goebell, P.J., Staehler, M., Müller, L., Nusch, A., Scheffler, M., Sauer, A., von Verschuer, U., Tech, S., Kruggel, L., Jänicke, M., Marschner, N., RCC-Registry Group… Weiterlesen Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials. Knauf, W., Aldaoud, A., Losem, C., Mittermueller, J., Neise, M., Niemeier, B., Harde, J., Trarbach, T., Potthoff, K., 2018. Leuk. Res. 68, 90–97. doi:10.1016/j.leukres.2018.03.008… Weiterlesen